Activate Biophysics Corp. (Activ8) is an established Canadian-based company which develops, manufactures, and sells scientifically formulated natural health products. This includes several unique immunity booster products, based on biophysics and cell signaling processes.
Activ8 previously manufactured popular sports supplements for performance and recovery, certified to rigorous international athletics standards and requirements. Athletes reported overwhelmingly positive responses, citing significant overall health improvements.
Our ILO enables you to participate in the growth of this incredible technology, which naturally optimises your health, eradicating immune challenges before they start.
PreImmunity products powerfully engage within minutes, with lasting beneficial effects and no toxicity. All formulas are based on succinate – which is fast becoming recognized as the single most functional metabolite in human health.
Succinate provides a critical signalling function to neighbouring cells and to the brain. PreImmunity products benefit from:
– Extensive worldwide research, development, and testing
– Successful human trials involving more than 450 people (in progress since 2015). Results indicate that PreImmunity effectively restored antioxidant efficiency levels, improved mood, and increased effectiveness during workouts
– Research demonstrates that in as little as 7-14 days, daily succinate supplements help restore sensitivity in the hypothalamus lost due to aging
– Patent pending across several succinate based formulas
PreImmunity is just about to launch on the market. The target market is broad, ranging from anyone looking to improve their health, to elite athletes and everyone in between. Our focus is to bring these products to market in North America, the EU and Asia.
Activ8 isn’t a regular pharmaceutical company – our mission is to promote optimal health by developing, manufacturing, and marketing non-toxic, highly effective dietary supplements throughout the world. Our sales are projected based on our proven business performance.
As we enter new markets, we are selling directly to companies who have demonstrated interest in PreImmunity. Many plan to roll PreImmunity out to their employees with the new-normal goal of increasing their defences against infection, decreasing sick days and increasing productivity. We also have additional non-toxic and highly effective products in the pipeline, ranging from cosmetic/therapeutic creams to specialty sports and energy drinks formulated with no caffeine, no additional sugar and no crash.
PreImmunity was formulated to support the signalling molecule succinate. When immunity is challenged, succinate is known to activate HIF and NRF2, two of the most powerful, natural genetic triggers found in practically every cell.
Each of these triggers then activates more than 100 genetic actions in your immune system which quickly restores homeostasis.
We know how to target a receptor to affect an action naturally, without toxicity. Restoring oxygen to cells and tissue is the secret to fueling our most powerful immune responses and homeostasis. Our products support homeostasis rather than replace it.
Activate Biophysics believes in providing our customers with all the science and facts behind our products upfront, and offers PreImmunity with our 45 day “Feel the Change” guarantee.
Activate Bio Physics Corp. are paying a:
12% royalty in year one
7% royalty in year two
5% royalty in year three
Activate Bio Physics Corp. have projected the following revenue figures for the term of their license:
In addition to paying you a royalty, at the end of the 3rd year Activate Bio Physics Corp. can choose to extend the license for another 3 years, or buy the ILO back for cash should Activate Bio Physics Corp. conduct a major financing.
ILO Value is the estimated value of your ILO in USD ($). This is calculated using our projected revenue numbers. Therefore if our revenue projections are realistic and achievable, this is a good estimation of the buy out price you should expect at different stages.
THIS AGREEMENT is between Activate Bio Physics Corp. (“the Company”), - AND – The Buyer who is the Current License Holder as determined by the Live Ledger held by ILOCX which holds details of licenses issued bought and sold (“the Buyer”).
May 27, 2021
Details of the Licensed Product are described on the Company’s page hosted on the site at www.ILOCX.com
None
Minimum Requirements for Qualification are a confirmed share of the Company’s information and Promotional Message on social media. This can be done on the ILOCX platform. Alternative ways to qualify are at the discretion of the company selling the license.
$10
Under the License Agreement the buyer is entitled to royalty payments once qualified
Each License receives a royalty equal to 12% of the Gross Revenues from the recorded and officially filed revenue, divided by 100000, the total amount of ILO Units in the Initial License Offering. All royalties will be paid to the Buyer’s wallet on the ILOCX platform within 5 days of payment settlement from the company. These days will be announced prior to release.
This License is for an Initial Term of 3 years at which time the License can be extended by the issuing Company for a further 3 years, (a “Rollover”) and new terms may be set by the company at this time in line with ILOCX exchange rules and guidelines. Alternatively, the Company may offer to buy the License back from the Buyer (“a ‘Buyback”). The Company will give notice of Rollover terms or Buyback Price 90 days before the end of the Initial Term, as outlined in the Buyer Terms and Conditions.
All licenses must be valid and deemed qualified to benefit from the Royalty and the Rollover or Buyback.
This Agreement should be read in conjunction with the License Terms and Conditions, the Company Terms and Conditions, the Buyer Terms and Conditions and the ILOCX Terms of Use which form part of this entire Agreement, as well all ILOCX rules, policies, rulings and procedural requirements (collectively the “ILOCX Terms and Conditions”).
All parties have read and agreed to comply with the ILOCX Terms and Conditions, this Agreement, and any documents included by reference above. These may be amended from time to time and the parties will be notified by email of such amendments. Breach of any of the terms of this agreement may result in termination of this Agreement under the termination procedures outlined in the License Terms and Conditions.
This Agreement shall be governed by the laws of England and Wales and the parties exclusively submit to the jurisdiction of the Courts of England and Wales. In the event of any dispute, refer to the terms and conditions for the procedure.
Agreed on behalf of the Company:
The Company confirms its consent to this License Agreement by presenting the ILO for sale on the ILOCX platform.
Agreed on behalf of the Buyer:
The Buyer consents to this agreement by completing their order on ILOCX.
Build your immunity while your build your ILO portfolio. Purchase at least one licenses to pre-order a Pre Immunity program.
Order NowActivate Biophysics Corp. Launches on ILOCX
Vancouver, British Columbia, Canada – May 5, 2021 – Activate Biophysics Corp. (“Activate”) is pleased to announce it has partnered up with the ILOCX and is eager to launch its ILO offering on their platform. Activate has signed a licensing agreement with ILOCX for the purpose of offering 100,000 licenses priced at US$10.00 each with a 12% royalty payable in the first year. Through the ILO offering Activate intends to further capitalize the company for product sales and further research and development.
